NCT00652262View on ClinicalTrials.gov

BAY38-9456 - Supportive Trial for Spinal Injury

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

November 30, 2004

Conditions

Erectile DysfunctionSexual DysfunctionSpinal Cord Injury

Interventions

DRUG

Levitra (Vardenafil, BAY38-9456)

Patients received BAY 38-9456 10 mg for the first 4 weeks of the treatment period, and then went on to receive 10 mg or 20 mg for the following 8 weeks.

Trial Locations (3)

455-8530

Nagoya

820-0053

Iizuka

874-0937

Beppu